New discovery could slow Alzheimer’s in its tracks
A new breakthrough is offering hope to people living with Alzheimer’s disease and their families. Praveen Nekkar, a professor at the University of Waterloo School of Pharmacy, has discovered that two common medications for depression and mood disorders — fluoxetine and paroxetine — have the potential to slow the advancement of Alzheimer’s disease and dementia. The finding, published in the journal ACS Chemical Neuroscience, is significant because it could be the key to preventing and ultimately curing the disease. It could not come at a more critical time, as the numbers of those living with Alzheimer’s disease reach epidemic proportions.